FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Legacy Pharmaceutical Packaging Losartan Potassium Tablets Recall

Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: The…

Legacy Pharmaceutical Packaging LLC · Earth City, MO

Risk level
Class II
Reported by FDA
May 8, 2019
Recall ID
D-1263-2019
Check your lot numberHow we source this data

Summary

Legacy Pharmaceutical Packaging recalled Losartan Potassium Tablets starting Apr 24, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1263-2019 on May 8, 2019. Reason: CGMP Deviations: Detection of trace amounts of N-Methylnitrosobutyric acid (NMBA) impurity found in the Active Pharmaceutical Ingredient (API). Status: Ongoing.

Why it was recalled

CGMP Deviations: Detection of trace amounts of N-Methylnitrosobutyric acid (NMBA) impurity found in the Active Pharmaceutical Ingredient (API)

Product description

Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: The Kroger Co, Cincinnati, OH 45202, Manufactured for: Torrent Pharma Inc., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045 NDC 68645-494-54

Lot numbers, UPCs & expiration codes

Lot 181598; 02/2021

Where it was sold

TN, AZ

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1263-2019
Classification
Class II
Status
Ongoing
Recall initiated
Apr 24, 2019
FDA report date
May 8, 2019
Quantity
60,012 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Legacy Pharmaceutical Packaging LLC

Original FDA data

Every field from FDA enforcement report D-1263-2019, exactly as published.

Show all FDA fields
City
Earth City
State
MO
Status
Ongoing
Country
United States
Event ID
82710
Address
13333 Lakefront Dr
Code information
Lot 181598; 02/2021
Postal code
63045-1514
Report date
May 8, 2019
Product type
Drugs
Recall number
D-1263-2019
Classification
Class II
Recalling firm
Legacy Pharmaceutical Packaging LLC
Product quantity
60,012 bottles
Reason for recall
CGMP Deviations: Detection of trace amounts of N-Methylnitrosobutyric acid (NMBA) impurity found in the Active Pharmaceutical Ingredient (API)
Voluntary / mandated
Voluntary: Firm initiated
Product description
Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: The Kroger Co, Cincinnati, OH 45202, Manufactured for: Torrent Pharma Inc., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045 NDC 68645-494-54
Distribution pattern
TN, AZ
Recall initiation date
Apr 24, 2019
Initial firm notification
Press Release
Center classification date
May 1, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1263-2019, published May 8, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls